(Q34178991)

English

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Laura C. Lazzeroni

object named as

Laura C Lazzeroni

6

0 references

author name string

Regina C Casper

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Allyson A Gilles

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Barry E Fleisher

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joan Baran

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Gregory Enns

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

16 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

217

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

211-219

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.1007/s00213-011-2270-z

0 references

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Maternal psychological distress during pregnancy in relation to child development at age two.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Association of Apgar score at five minutes with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Placental passage of antidepressant medications

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

New perspectives on the neurodevelopmental effects of SSRIs

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Antidepressants in amniotic fluid: another route of fetal exposure.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Neurodevelopment of children exposed in utero to antidepressant drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2270-Z

21 January 2018

Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Birth outcomes in pregnant women taking fluoxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and function of the brain serotonin system

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499702

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-011-2270-Z

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34178991&oldid=1980515883"